A new analysis of adjuvant radiation therapy in women with breast cancer following mastectomy is associated with better survival as measured at 10 years when appropriate doses and fields of radiation are used. The study was published in the January 4 issue of the Journal of the National Cancer Institute . The finding helps resolve controversy over whether radiation therapy improves both survival and risk of recurrence in women with operable breast cancer.

Past studies of radiation therapy in women with operable breast cancer have led to the conclusion that radiation therapy reduces the risk of recurrence of breast cancer but the effects on overall survival have been less clear. However, in some clinical trials, radiation therapy was given in inadequate or excessive doses or did not target an appropriate amount of tissue, including the chest wall and lymph nodes.

Val Gebski, of the National Health and Medical Research Council Clinical Trials Centre in New South Wales, Australia, and colleagues reanalyzed results from 36 clinical trials in which the use of radiation therapy was the sole difference between treatments given to breast cancer patients. They divided trials into three categories: category 1, for studies that used optimal radiation doses delivered to an appropriate amount of tissue; category 2, for studies where patients received an inadequate or excessive dose of radiation; and category 3, for studies in which an inadequate amount of tissue was treated with radiation therapy.

At 5 years, patients in category 1 studies had a 2.9% absolute increase in survival with radiation therapy than without. At 10 years, patients in category 1 studies had a 6.4% absolute increase in survival. In category 2 and 3 studies, radiation therapy was not associated with a difference in overall survival after 5 or 10 years of follow-up. Gebski and colleagues conclude that optimal radiation therapy improves patient survival, measured at bot
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
3-Jan-2006

Page: 1 2
Related biology news :

1. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
2. Brightly colored birds most affected by Chernobyl radiation
3. Enzyme delivered in smaller package protects cells from radiation damage
4. Virtual Patient to simulate real-time organ motions for radiation therapy
5. Einstein researchers discover radiation-eating fungi
6. Combining NSAIDs with chemotherapy, radiation may improve cancer treatment
7. Researchers uncover protection mechanism of radiation-resistant bacterium
8. One small step for Deinococcus or one giant leap for radiation biology?
9. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
10. Targeted irradiation: A new weapon against HIV?
11. Towards predicting late-stage radiation toxicity